Stanley Lapidus, Director at Lucid Diagnostics Inc. (LUCD), sold 29,947 shares at $1.43 ($43K) on 2023-09-25, disclosed to the SEC on 2023-09-27.
Scheduled sale ($43k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.43 | 200 | $286 | 0.7% |
| 2 | $1.43 | 10,000 | $14K | 32.9% |
| 3 | $1.45 | 9,747 | $14K | 32.6% |
| 4 | $1.47 | 10,000 | $15K | 33.9% |
| Total | $1.45 avg | 29,947 | $43K | 100% |
| Filing → |
| TTOO | SELL | 2019-06-13 | $13K | — | Filing → |
| TTOO | SELL | 2018-11-08 | $32K | — | Filing → |
| TTOO | SELL | 2018-06-05 | $53K | — | Filing → |